Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFX.L Regulatory News (AFX)

  • There is currently no data for AFX

Trading Update

8 Dec 2021 07:00

RNS Number : 8960U
Alpha FX Group PLC
08 December 2021
 

8 December 2021

Alpha FX Group plc

("Alpha FX" or the "Group")

Trading Update

 

Alpha FX Group plc (AIM: AFX), a leading provider of high-tech, high-touch FX risk management and alternative banking solutions to corporates and institutions globally, today announces a trading update for the financial year ending 31 December 2021.

 

Following our interim results announcement on 1 September 2021, the Board is pleased to announce that trading has remained strong. Growth continues to be derived from the Group's core Corporate & Institutional FX Risk Management divisions in London, alongside record half year performances, already achieved in H2 to date, from all three of the Group's newer divisions: Alpha Netherlands, Alpha Canada and Alpha Platform Solutions.

 

We anticipated in our interim report that as part of our strategy to invest for future growth, costs would accelerate in the second half of the year as the restrictions posed by COVID eased further. This has indeed been the case, in particular from increased hiring in both Front and Back Office across all divisions.

 

Despite this increase in costs, as a result of the continued strong trading since 1 September 2021, the Board now expects that revenue and earnings for the year will be ahead of most recent expectations.

 

A more detailed trading update will be provided as usual in January 2022.

 

 

Enquiries:

 

Alpha FX Group plc

via Alma PR

Morgan Tillbrook, Founder and CEO

Tim Kidd, CFO

Liberum Capital Limited 

(Nominated Adviser and Sole Broker)

Tel: +44 (0) 20 3100 2000

Neil Patel

Cameron Duncan

Kane Collings

Alma PR (Financial Public Relations)

Tel: +44 (0) 20 3405 0205

Josh Royston

Andy Bryant

Kieran Breheny

 

Market Abuse Regulation

The information contained within this announcement is deemed by Alpha FX Group plc to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019. The person who arranged for the release of this announcement on behalf of Alpha FX Group plc was Tim Kidd, Chief Financial Officer.

Notes to Editors

Alpha provides FX risk management and alternative banking solutions to corporates and institutions across the UK, Europe and Canada. Combining leading expertise and technology, the Group partners with a small number of high value clients, to provide enterprise-level solutions across four key areas: FX risk management, international payments, accounts and collections.

 

Since it was incorporated in 2010, Alpha FX has been able to build and retain a high-quality client base that includes a number of highly respected brands.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDKOBPFBDDQBK
Date   Source Headline
14th Dec 20215:59 pmRNSHolding(s) in Company
8th Dec 20217:00 amRNSTrading Update
23rd Nov 20212:00 pmRNSPrice Monitoring Extension
7th Oct 20217:00 amRNSBoard Appointment
4th Oct 20214:19 pmRNSHolding(s) in Company
29th Sep 20217:00 amRNSLaunch of next-generation banking platform
9th Sep 20212:44 pmRNSIssue of Equity
1st Sep 20217:00 amRNSInterim Report
13th Aug 202110:57 amRNSHolding(s) in Company
16th Jul 202110:29 amRNSHolding(s) in Company
14th Jul 20217:00 amRNSTrading Update
28th May 20217:00 amRNSNetherlands Office Share Ownership Scheme
27th May 20211:50 pmRNSDirector/PDMR Dealing
27th May 20217:00 amRNSTrading Update
19th May 20217:00 amRNSBoard Appointment
5th May 202110:53 amRNSResult of AGM
15th Apr 20217:00 amRNSExercise of Options
13th Apr 20217:00 amRNSDirector/PDMR Shareholding
9th Apr 20217:00 amRNSNotice of AGM & Posting of Annual Report
23rd Mar 20214:16 pmRNSDirector/PDMR Dealings
17th Mar 20217:00 amRNSFull Year Results
22nd Feb 20215:56 pmRNSHolding(s) in Company
18th Feb 20212:56 pmRNSReplacement - Holding(s) in Company
12th Jan 20217:00 amRNSTrading Update
3rd Dec 20207:00 amRNSTrading Update
2nd Nov 20207:00 amRNSDirectorate Change
1st Oct 20207:00 amRNSTrading Update
30th Sep 20204:31 pmRNSHolding(s) in Company
16th Sep 20209:44 amRNSHolding(s) in Company
16th Sep 20209:42 amRNSHolding(s) in Company
11th Sep 20203:42 pmRNSHolding(s) in Company
11th Sep 202010:59 amRNSOption Exercise and Total Voting Rights
10th Sep 20201:30 pmRNSResult of secondary placing of Ordinary Shares
10th Sep 20207:00 amRNSProposed secondary placing of Ordinary Shares
2nd Sep 20207:00 amRNSInterim Report
13th Aug 20207:00 amRNSExercise of Options
15th Jul 20204:40 pmRNSSecond Price Monitoring Extn
15th Jul 20204:35 pmRNSPrice Monitoring Extension
15th Jul 20207:00 amRNSTrading Update
6th Jul 20205:12 pmRNSReplacement: Holding(s) in Company
6th Jul 20209:22 amRNSHolding(s) in Company
6th Jul 20209:20 amRNSHolding(s) in Company
24th Jun 202010:36 amRNSResult of AGM
19th Jun 20201:40 pmRNSDirector/PDMR Shareholding
2nd Jun 20203:59 pmRNSHolding(s) in Company
1st Jun 20202:07 pmRNSNotice of Annual General Meeting
19th May 20207:00 amRNSJames Carey Appointed Director of Technology
11th May 20207:00 amRNSUpdate on Employee Share Schemes and Board Update
20th Apr 20207:00 amRNSDirectorate Change
9th Apr 20205:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.